Literature DB >> 17665255

Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis.

Tomohiko Moriyama1, Takayuki Matsumoto, Shotaro Nakamura, Yukihiko Jo, Ryuichi Mibu, Takashi Yao, Mitsuo Iida.   

Abstract

PURPOSE: The microsatellite instability and CpG island hypermethylation of p14 ( ARF ) and p16 ( INK4a ) are related to the pathogenesis of neoplasia in ulcerative colitis. This study was designed to assess the significance of those genetic or epigenetic alterations for cancer surveillance in ulcerative colitis.
METHODS: During surveillance colonoscopy in 39 patients with ulcerative colitis, biopsy specimens were obtained from the cecum and the rectum as well as from any other areas suspected of being neoplasia by chromoscopy. Using DNA extracts, the methylation status of p14 ( ARF ) and p16 ( INK4a ) and the microsatellite status were determined.
RESULTS: Microsatellite instability was positive in one of five dysplasias, but it was negative in the cecum and the rectum. The incidence of hypermethylation of p14 ( ARF ) was 0 percent in the cecum, 26 percent in the rectum, and 100 percent in dysplasia, whereas that of p16 ( INK4a ) was 10, 10, and 0 percent, respectively. Patients who were positive for the hypermethylation of p14 ( ARF )in the rectum had a longer duration of ulcerative colitis than those who were negative for such hypermethylation. Two of 10 patients who were positive for p14 ( ARF ) hypermethylation in the rectum and 1 of 29 patients who were negative for the hypermethylation had dysplasia. During the subsequent surveillance of 36 patients, dysplasia was detected in 2 of 8 patients with p14 ( ARF ) hypermethylation and in none of 28 patients without hypermethylation (P = 0.044).
CONCLUSIONS: In patients with ulcerative colitis, hypermethylation of p14 ( ARF ) seems to be associated with an early stage of dysplasia. The hypermethylation may be one of candidates for potential biomarker to identify patients at a high risk of dysplasia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17665255     DOI: 10.1007/10350-007-0302-x

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  17 in total

Review 1.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 2.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

Review 3.  Ulcerative colitis-associated colorectal cancer.

Authors:  Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 4.  [Pathogenesis of colitis-associated neoplasms].

Authors:  M Vieth; H Neumann
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

5.  Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.

Authors:  J B Kisiel; T C Yab; F T Nazer Hussain; W R Taylor; M M Garrity-Park; W J Sandborn; E V Loftus; B G Wolff; T C Smyrk; S H Itzkowitz; D T Rubin; H Zou; D W Mahoney; D A Ahlquist
Journal:  Aliment Pharmacol Ther       Date:  2013-01-24       Impact factor: 8.171

Review 6.  Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer.

Authors:  Linda A Feagins; Rhonda F Souza; Stuart J Spechler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-05       Impact factor: 46.802

7.  Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia.

Authors:  Mashaal Dhir; Elizabeth A Montgomery; Sabine C Glöckner; Kornel E Schuebel; Craig M Hooker; James G Herman; Stephen B Baylin; Susan L Gearhart; Nita Ahuja
Journal:  J Gastrointest Surg       Date:  2008-08-21       Impact factor: 3.452

8.  DNA methylation of microRNA-124a is a potential risk marker of colitis-associated cancer in patients with ulcerative colitis.

Authors:  Yuko Ueda; Takayuki Ando; Sohachi Nanjo; Toshikazu Ushijima; Toshiro Sugiyama
Journal:  Dig Dis Sci       Date:  2014-05-10       Impact factor: 3.199

9.  Hypermethylation of Corticotropin Releasing Hormone Receptor-2 Gene in Ulcerative Colitis Associated Colorectal Cancer.

Authors:  Masayoshi Kobayashi; Nagahide Matsubara; Yutaka Nakachi; Yasushi Okazaki; Motoi Uchino; Hiroki Ikeuchi; Jihyng Song; Kei Kimura; Michiko Yasuhara; Akihito Babaya; Tomoki Yamano; Masataka Ikeda; Hiroki Nishikawa; Ikuo Matsuda; Seiichi Hirota; Naohiro Tomita
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

10.  Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection.

Authors:  Giles O Elliott; Ian T Johnson; Jane Scarll; Jack Dainty; Elizabeth A Williams; D Garg; Amanda Coupe; David M Bradburn; John C Mathers; Nigel J Belshaw
Journal:  Int J Colorectal Dis       Date:  2012-07-13       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.